PyInvesting

Market research

001060.KO JW Pharmaceutical Corporation

KO KRW Healthcare

Latest close

23,500.00 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
522B
P/E ratio
10.61
Analyst target
34000
Dividend yield
2.8%
Beta
1.05

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

JW Pharmaceutical Corporation is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.

From a valuation standpoint, the stock is 86.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.

JW Pharmaceutical Corporation's total revenue rose by 27.0% to $145B since the same quarter in the previous year.

Its net income has increased by 70.1% to $-7B since the same quarter in the previous year.

Finally, its free cash flow fell by 65.1% to $9B since the same quarter in the previous year.

Based on the above factors, JW Pharmaceutical Corporation gets an overall score of 4/5.